Terms: = Liver cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546
14 results:
1. Potential role of
Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
[TBL] [Abstract] [Full Text] [Related]
2. Safety of pylorus-preserving gastrectomy for gastric cancer combined with antral high-risk lesions: a comparison with endoscopic submucosal dissection.
Choi J; Kim S; Chung H; Kong SH; Cho SJ; Park DJ; Lee HJ; Kim SG; Yang HK
Surg Endosc; 2023 Apr; 37(4):2987-2996. PubMed ID: 36517703
[TBL] [Abstract] [Full Text] [Related]
3. Correlation of Non-tumoral liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
Webster LA; Villalobos A; Cheng B; Xing M; Majdalany BS; Bercu ZL; Cristescu MM; Brandon D; Schuster D; Baum Y; Loya MF; Kokabi N
Cardiovasc Intervent Radiol; 2023 Jan; 46(1):60-68. PubMed ID: 36450996
[TBL] [Abstract] [Full Text] [Related]
4. The first competing risk survival nomogram in patients with papillary renal cell carcinoma.
Su X; Hou NN; Yang LJ; Li PX; Yang XJ; Hou GD; Gao XL; Ma SJ; Guo F; Zhang R; Zhang WH; Qin WJ; Wang FL
Sci Rep; 2021 Jun; 11(1):11835. PubMed ID: 34088935
[TBL] [Abstract] [Full Text] [Related]
5.
Nikpanah M; Paschall AK; Ahlman MA; Civelek AC; Farhadi F; Mirmomen SM; Li X; Saboury B; Ball MW; Merino MJ; Srinivasan R; Jones EC; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2021 Jul; 46(7):3301-3308. PubMed ID: 33688985
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
Dudani S; de Velasco G; Wells JC; Gan CL; Donskov F; Porta C; Fraccon A; Pasini F; Lee JL; Hansen A; Bjarnason GA; Beuselinck B; Pal SK; Yuasa T; Kroeger N; Kanesvaran R; Reaume MN; Canil C; Choueiri TK; Heng DYC
JAMA Netw Open; 2021 Jan; 4(1):e2021869. PubMed ID: 33475752
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract] [Full Text] [Related]
8. Activity of lenvatinib plus everolimus combination in a heavily pretreated patient with papillary renal cell carcinoma: a case report.
Zielli T; Gnetti L; Buti S
Tumori; 2020 Dec; 106(6):NP79-NP83. PubMed ID: 32458743
[TBL] [Abstract] [Full Text] [Related]
9. Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Naglieri E; Niccoli Asabella A; Nappi AG; Carella C; Ferrari C; Rubini G
Medicine (Baltimore); 2019 Dec; 98(50):e18093. PubMed ID: 31852068
[TBL] [Abstract] [Full Text] [Related]
10. Recurrent renal cell carcinoma leading to a misdiagnosis of polycystic liver disease: A case report.
Liang C; Takahashi K; Kurata M; Sakashita S; Oda T; Ohkohchi N
World J Gastroenterol; 2019 May; 25(18):2264-2270. PubMed ID: 31143076
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathologic analysis of papillary renal cell carcinoma].
Zhang W; Li YJ
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):354-8. PubMed ID: 20723433
[TBL] [Abstract] [Full Text] [Related]
12. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.
Kosaka T; Mikami S; Miyajima A; Oya M
Clin Exp Nephrol; 2008 Apr; 12(2):155-158. PubMed ID: 18209950
[TBL] [Abstract] [Full Text] [Related]
14. Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.
Simon-Kayser B; Scoul C; Renaudin K; Jezequel P; Bouchot O; Rigaud J; Bezieau S
Genes Chromosomes Cancer; 2005 May; 43(1):83-94. PubMed ID: 15723337
[TBL] [Abstract] [Full Text] [Related]
